title: Silence of ezrin modifies migration and actin cytoskeleton rearrangements and enhances chemosensitivity of lung cancer cells in vitro.
abstract: Ezrin, primarily acts as a linker between the plasma membrane and the cytoskeleton, is involved in many cellular functions, including regulation of actin cytoskeleton, control of cell shape, adhesion, motility, and modulation of signaling pathways. Although ezrin is now recognized as a key component in tumor metastasis, its roles and the underlying mechanisms remain unclear. In the present study, we chose highly metastatic human lung carcinoma 95D cells, which highly express the ezrin proteins, as a model to examine the functional roles of ezrin in tumor suppression. An ezrin-silenced 95D cell line was established using lentivirus-mediated short hairpin RNA method. CCK-8 assay and soft agar assay analysis showed that downregulation of ezrin significantly suppressed the tumorigenicity and proliferation of 95D cells in vitro. cell migration and invasion studies showed that ezrin-specific deficiency in the cells caused the substantial reduction of the cell migration and invasion. In parallel, it also induced rearrangements of the actin cytoskeleton. Flow cytometry assay showed that changes in the ezrin protein level significantly affected the cell cycle distribution and eventual apoptosis. Furthermore, further studies showed that ezrin regulated the expression level of E-cadherin and CD44, which are key molecules involved in cell growth, migration, and invasion. Meanwhile, the suppression of ezrin expression also sensitized cells to antitumor drugs. Altogether, our results demonstrated that ezrin played an important role in the tumorigenicity and metastasis of lung cancer cells, which will benefit the development of therapeutic strategy for lung cancer.
authors: Department of Respiratory Disease, The 117th Hospital of PLA, Hang Zhou, People's Republic of China. cqyong117@163.com
authors: Qing-Yong
authors: QY
authors: Chen
authors: Wei
authors: W
authors: Xu
authors: De-Min
authors: DM
authors: Jiao
authors: Li-Jun
authors: LJ
authors: Wu
authors: Jia
authors: J
authors: Song
authors: Jie
authors: J
authors: Yan
authors: Jian-Guo
authors: JG
authors: Shi
mesh_terms: D008841:Actin Cytoskeleton / Q000378:metabolism*; D015703:Antigens, CD; D000970:Antineoplastic Agents / Q000494:pharmacology*; D017209:Apoptosis; D015820:Cadherins / Q000378:metabolism; D002453:Cell Cycle; D045744:Cell Line, Tumor; D002465:Cell Movement; D049109:Cell Proliferation; D002945:Cisplatin / Q000494:pharmacology*; D003598:Cytoskeletal Proteins / Q000235:genetics* / Q000378:metabolism; D019008:Drug Resistance, Neoplasm; D015870:Gene Expression; D055785:Gene Knockdown Techniques; D006801:Humans; D018960:Hyaluronan Receptors / Q000378:metabolism; D034741:RNA, Small Interfering / Q000235:genetics; D000099149:Ezrin
chemical_list: D015703:Antigens, CD; D000970:Antineoplastic Agents; D015820:Cadherins; D002945:Cisplatin; D003598:Cytoskeletal Proteins; D018960:Hyaluronan Receptors; D034741:RNA, Small Interfering; D000099149:Ezrin; C497483:CD44 protein, human; C513384:CDH1 protein, human